--- title: 'Manufacturing Daily Summary: What Happened on October 15, 2026' headline: Domestic drug production could reduce, not end, shortage risk description: A manufacturing lawyer says US production and local supply chains may help, while shortages have multiple causes. url: https://thebench.bio/news/manufacturing/2026-10-15 topic: manufacturing date: '2026-10-15' covers: - '2026-10-15' date_published: '2026-10-15T12:03:07Z' date_modified: '2026-10-15T12:03:07Z' tags: - Manufacturing sources: 1 publisher: TheBench.Bio --- # Manufacturing Daily Summary: What Happened on October 15, 2026 **Domestic drug production could reduce, not end, shortage risk** A manufacturing lawyer says US production and local supply chains may help, while shortages have multiple causes. ## Today in brief Marc Wagner said expanding US pharmaceutical production could lower drug-shortage risk, but not eliminate it. [1] ## Manufacturing Most generic drug products are made outside the United States, Wagner said, leaving overseas facilities to help meet supply needs. [1] He said restoring domestic production of active pharmaceutical ingredients and localizing supply chains could reduce manufacturing disruptions. [1] Domestic facilities are easier for the FDA to inspect, with less travel and resource burden, Wagner said. [1] Shortages have multiple causes, and no single measure can solve them, he said. [1] ## Sources 1. [The Impact That the Renewed Focus on Domestic Manufacturing Might Have on the Supply Chain](), Pharmaceutical Executive, 2026-10-15 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: